204 related articles for article (PubMed ID: 26113609)
1. mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity.
Finetti F; Terzuoli E; Giachetti A; Santi R; Villari D; Hanaka H; Radmark O; Ziche M; Donnini S
Endocr Relat Cancer; 2015 Aug; 22(4):665-78. PubMed ID: 26113609
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition of microsomal prostaglandin E synthase-1 suppresses epidermal growth factor receptor-mediated tumor growth and angiogenesis.
Finetti F; Terzuoli E; Bocci E; Coletta I; Polenzani L; Mangano G; Alisi MA; Cazzolla N; Giachetti A; Ziche M; Donnini S
PLoS One; 2012; 7(7):e40576. PubMed ID: 22815767
[TBL] [Abstract][Full Text] [Related]
3. Necrosis in DU145 prostate cancer spheroids induces COX-2/mPGES-1-derived PGE2 to promote tumor growth and to inhibit T cell activation.
Sha W; Olesch C; Hanaka H; Rådmark O; Weigert A; Brüne B
Int J Cancer; 2013 Oct; 133(7):1578-88. PubMed ID: 23536473
[TBL] [Abstract][Full Text] [Related]
4. EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicity.
Donnini S; Finetti F; Terzuoli E; Giachetti A; Iñiguez MA; Hanaka H; Fresno M; Rådmark O; Ziche M
Oncogene; 2012 Jul; 31(29):3457-66. PubMed ID: 22081067
[TBL] [Abstract][Full Text] [Related]
5. Linking of mPGES-1 and iNOS activates stem-like phenotype in EGFR-driven epithelial tumor cells.
Terzuoli E; Finetti F; Costanza F; Giachetti A; Ziche M; Donnini S
Nitric Oxide; 2017 Jun; 66():17-29. PubMed ID: 28257996
[TBL] [Abstract][Full Text] [Related]
6. Roles of microsomal prostaglandin E synthase-1 in lung metastasis formation in prostate cancer RM9 cells.
Takahashi R; Amano H; Satoh T; Tabata K; Ikeda M; Kitasato H; Akira S; Iwamura M; Majima M
Biomed Pharmacother; 2014 Feb; 68(1):71-7. PubMed ID: 24291175
[TBL] [Abstract][Full Text] [Related]
7. Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells.
Hanaka H; Pawelzik SC; Johnsen JI; Rakonjac M; Terawaki K; Rasmuson A; Sveinbjörnsson B; Schumacher MC; Hamberg M; Samuelsson B; Jakobsson PJ; Kogner P; Rådmark O
Proc Natl Acad Sci U S A; 2009 Nov; 106(44):18757-62. PubMed ID: 19846775
[TBL] [Abstract][Full Text] [Related]
8. Linking microsomal prostaglandin E Synthase-1/PGE-2 pathway with miR-15a and -186 expression: Novel mechanism of VEGF modulation in prostate cancer.
Terzuoli E; Donnini S; Finetti F; Nesi G; Villari D; Hanaka H; Radmark O; Giachetti A; Ziche M
Oncotarget; 2016 Jul; 7(28):44350-44364. PubMed ID: 27322147
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 produced by inducible COX-2 and mPGES-1 promoting cancer cell proliferation in vitro and in vivo.
Ruan D; So SP
Life Sci; 2014 Oct; 116(1):43-50. PubMed ID: 25139833
[TBL] [Abstract][Full Text] [Related]
10. mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines.
Terzuoli E; Costanza F; Ciccone V; Ziche M; Morbidelli L; Donnini S
Prostaglandins Other Lipid Mediat; 2019 Aug; 143():106344. PubMed ID: 31207300
[TBL] [Abstract][Full Text] [Related]
11. Expression and significance of microsomal prostaglandin synthase-1 (mPGES-1) and Beclin-1 in the development of prostate cancer.
Xu LW; Qian M; Jia RP; Xu Z; Wu JP; Li WC; Huang WB; Chen XG
Asian Pac J Cancer Prev; 2012; 13(4):1639-44. PubMed ID: 22799381
[TBL] [Abstract][Full Text] [Related]
12. Sonlicromanol's active metabolite KH176m normalizes prostate cancer stem cell mPGES-1 overexpression and inhibits cancer spheroid growth.
Jiang X; Renkema H; Smeitink J; Beyrath J
PLoS One; 2021; 16(7):e0254315. PubMed ID: 34242345
[TBL] [Abstract][Full Text] [Related]
13. COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset.
Larsson K; Kock A; Idborg H; Arsenian Henriksson M; Martinsson T; Johnsen JI; Korotkova M; Kogner P; Jakobsson PJ
Proc Natl Acad Sci U S A; 2015 Jun; 112(26):8070-5. PubMed ID: 26080408
[TBL] [Abstract][Full Text] [Related]
14. Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.
Koeberle A; Werz O
Biochem Pharmacol; 2015 Nov; 98(1):1-15. PubMed ID: 26123522
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Ren D; Yang Q; Dai Y; Guo W; Du H; Song L; Peng X
Mol Cancer; 2017 Jul; 16(1):117. PubMed ID: 28693582
[TBL] [Abstract][Full Text] [Related]
16. Sulforaphane inhibits prostaglandin E2 synthesis by suppressing microsomal prostaglandin E synthase 1.
Zhou J; Joplin DG; Cross JV; Templeton DJ
PLoS One; 2012; 7(11):e49744. PubMed ID: 23166763
[TBL] [Abstract][Full Text] [Related]
17. Microsomal prostaglandin E synthase-1 in both cancer cells and hosts contributes to tumour growth, invasion and metastasis.
Kamei D; Murakami M; Sasaki Y; Nakatani Y; Majima M; Ishikawa Y; Ishii T; Uematsu S; Akira S; Hara S; Kudo I
Biochem J; 2009 Dec; 425(2):361-71. PubMed ID: 19845504
[TBL] [Abstract][Full Text] [Related]
18. MPGES-1-derived PGE2 suppresses CD80 expression on tumor-associated phagocytes to inhibit anti-tumor immune responses in breast cancer.
Olesch C; Sha W; Angioni C; Sha LK; Açaf E; Patrignani P; Jakobsson PJ; Radeke HH; Grösch S; Geisslinger G; von Knethen A; Weigert A; Brüne B
Oncotarget; 2015 Apr; 6(12):10284-96. PubMed ID: 25871398
[TBL] [Abstract][Full Text] [Related]
19. Tumor cells induce COX-2 and mPGES-1 expression in microvascular endothelial cells mainly by means of IL-1 receptor activation.
Casós K; Siguero L; Fernández-Figueras MT; León X; Sardá MP; Vila L; Camacho M
Microvasc Res; 2011 May; 81(3):261-8. PubMed ID: 21277871
[TBL] [Abstract][Full Text] [Related]
20. MF63 [2-(6-chloro-1H-phenanthro[9,10-d]imidazol-2-yl)-isophthalonitrile], a selective microsomal prostaglandin E synthase-1 inhibitor, relieves pyresis and pain in preclinical models of inflammation.
Xu D; Rowland SE; Clark P; Giroux A; Côté B; Guiral S; Salem M; Ducharme Y; Friesen RW; Méthot N; Mancini J; Audoly L; Riendeau D
J Pharmacol Exp Ther; 2008 Sep; 326(3):754-63. PubMed ID: 18524979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
